Vortioxetine
SToP-C
Phase 3 small_molecule completed
Quick answer
Vortioxetine for Cannabis Use Disorder is a Phase 3 program (small_molecule) at The University of Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The University of Hong Kong
- Indication
- Cannabis Use Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed